Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-25-000413

EVP & Chief Financial Officer sold 3,770 shares at an average $21.38 ($80,615)

From the SEC's structured data for this filing

Trades in this filing

Schorno Dean L · EVP & Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-04 Sale : show line 1 in the form −2,036 $20.92 $42,595 58,969 D
2025-02-05 Sale : show line 2 in the form −1,734 $21.93 $38,020 57,235 D
Open-market sales · 3,770 sh · avg $21.38 · $80,615
Loading xslF345X05/form4.xml…